Business, News Samsung Bioepis Launches OPUVIZ™ (Aflibercept) 40 mg/mL Vial Across Europe, to Treat Ophthalmic Conditions by Business Wire • 2026/05/29 • 0 Comments INCHEON, Korea--(BUSINESS WIRE)-- #Europe--Samsung Bioepis launches Opuviz (aflibercept) in Europe.